Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C

Amanda Mocroft, Jurgen Rockstroh, Vincent Soriano, Ole Kirk, Jean Paul Viard, Saulius Caplinskas, Jacek Gasiorowski, Antonio Chiesi, Andrew N. Phillips, Jens D. Lundgren

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Uptake of hepatitis C (HCV) treatment in HIV-coinfected patients is not well described. Of 2356 HCV-seropositive patients, 180 (7.6%) started HCV treatment with interferon-based therapies. In multivariate Poisson-regression models, there was a 38% increase per year in the incidence of starting HCV treatment (95% CI 26-51%, p <0.0001); this increased from 3.9 per 1000 person-years follow-up (PYFU) before 1998 (95% CI 1.6-6.1) to 32.6 per 1000 PYFU at/after 2004 (95% CI 22.5-42.7). Although prescription of HCV therapy is increasing in HIV-coinfected patients, it remains infrequent and variable across regions of Europe.

Original languageEnglish
Pages (from-to)1092-1097
Number of pages6
JournalScandinavian Journal of Infectious Diseases
Volume38
Issue number11-12
DOIs
Publication statusPublished - Nov 2006
Externally publishedYes

Fingerprint

Hepatitis C
HIV
Therapeutics
Interferons
Prescriptions
Incidence

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology

Cite this

Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C. / Mocroft, Amanda; Rockstroh, Jurgen; Soriano, Vincent; Kirk, Ole; Viard, Jean Paul; Caplinskas, Saulius; Gasiorowski, Jacek; Chiesi, Antonio; Phillips, Andrew N.; Lundgren, Jens D.

In: Scandinavian Journal of Infectious Diseases, Vol. 38, No. 11-12, 11.2006, p. 1092-1097.

Research output: Contribution to journalArticle

Mocroft, A, Rockstroh, J, Soriano, V, Kirk, O, Viard, JP, Caplinskas, S, Gasiorowski, J, Chiesi, A, Phillips, AN & Lundgren, JD 2006, 'Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C', Scandinavian Journal of Infectious Diseases, vol. 38, no. 11-12, pp. 1092-1097. https://doi.org/10.1080/00365540600786515
Mocroft, Amanda ; Rockstroh, Jurgen ; Soriano, Vincent ; Kirk, Ole ; Viard, Jean Paul ; Caplinskas, Saulius ; Gasiorowski, Jacek ; Chiesi, Antonio ; Phillips, Andrew N. ; Lundgren, Jens D. / Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C. In: Scandinavian Journal of Infectious Diseases. 2006 ; Vol. 38, No. 11-12. pp. 1092-1097.
@article{83283389cb864cbda0740a9812d50ce6,
title = "Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C",
abstract = "Uptake of hepatitis C (HCV) treatment in HIV-coinfected patients is not well described. Of 2356 HCV-seropositive patients, 180 (7.6{\%}) started HCV treatment with interferon-based therapies. In multivariate Poisson-regression models, there was a 38{\%} increase per year in the incidence of starting HCV treatment (95{\%} CI 26-51{\%}, p <0.0001); this increased from 3.9 per 1000 person-years follow-up (PYFU) before 1998 (95{\%} CI 1.6-6.1) to 32.6 per 1000 PYFU at/after 2004 (95{\%} CI 22.5-42.7). Although prescription of HCV therapy is increasing in HIV-coinfected patients, it remains infrequent and variable across regions of Europe.",
author = "Amanda Mocroft and Jurgen Rockstroh and Vincent Soriano and Ole Kirk and Viard, {Jean Paul} and Saulius Caplinskas and Jacek Gasiorowski and Antonio Chiesi and Phillips, {Andrew N.} and Lundgren, {Jens D.}",
year = "2006",
month = "11",
doi = "10.1080/00365540600786515",
language = "English",
volume = "38",
pages = "1092--1097",
journal = "Scandinavian Journal of Infectious Diseases",
issn = "0036-5548",
publisher = "Informa Healthcare",
number = "11-12",

}

TY - JOUR

T1 - Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C

AU - Mocroft, Amanda

AU - Rockstroh, Jurgen

AU - Soriano, Vincent

AU - Kirk, Ole

AU - Viard, Jean Paul

AU - Caplinskas, Saulius

AU - Gasiorowski, Jacek

AU - Chiesi, Antonio

AU - Phillips, Andrew N.

AU - Lundgren, Jens D.

PY - 2006/11

Y1 - 2006/11

N2 - Uptake of hepatitis C (HCV) treatment in HIV-coinfected patients is not well described. Of 2356 HCV-seropositive patients, 180 (7.6%) started HCV treatment with interferon-based therapies. In multivariate Poisson-regression models, there was a 38% increase per year in the incidence of starting HCV treatment (95% CI 26-51%, p <0.0001); this increased from 3.9 per 1000 person-years follow-up (PYFU) before 1998 (95% CI 1.6-6.1) to 32.6 per 1000 PYFU at/after 2004 (95% CI 22.5-42.7). Although prescription of HCV therapy is increasing in HIV-coinfected patients, it remains infrequent and variable across regions of Europe.

AB - Uptake of hepatitis C (HCV) treatment in HIV-coinfected patients is not well described. Of 2356 HCV-seropositive patients, 180 (7.6%) started HCV treatment with interferon-based therapies. In multivariate Poisson-regression models, there was a 38% increase per year in the incidence of starting HCV treatment (95% CI 26-51%, p <0.0001); this increased from 3.9 per 1000 person-years follow-up (PYFU) before 1998 (95% CI 1.6-6.1) to 32.6 per 1000 PYFU at/after 2004 (95% CI 22.5-42.7). Although prescription of HCV therapy is increasing in HIV-coinfected patients, it remains infrequent and variable across regions of Europe.

UR - http://www.scopus.com/inward/record.url?scp=33845300571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845300571&partnerID=8YFLogxK

U2 - 10.1080/00365540600786515

DO - 10.1080/00365540600786515

M3 - Article

C2 - 17148084

AN - SCOPUS:33845300571

VL - 38

SP - 1092

EP - 1097

JO - Scandinavian Journal of Infectious Diseases

JF - Scandinavian Journal of Infectious Diseases

SN - 0036-5548

IS - 11-12

ER -